Trials / Conditions / Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant
3 registered clinical trials studyying Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole NCT03092193 | University of Sao Paulo | Phase 4 |
| Completed | Pharmacogenetic Testing Among Home Health Patients NCT02378220 | Genelex Corporation | N/A |
| Completed | YouScript IMPACT Registry NCT02191358 | Genelex Corporation | — |